Shannon Cress Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 134 S Penn Ave, Harrisville, WV 26362 Phone: 304-643-2991 |
Kelsey Waggoner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 134 S Penn Ave, Harrisville, WV 26362 Phone: 304-643-2991 |
Gregory Lipsmeyer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 134 S Penn Ave, Harrisville, WV 26362 Phone: 304-643-2991 |
News Archive
In the current issue of Psychotherapy and Psychosomatic Dr. Ralph Horwitz and colleagues outline new methodologies, in addition to the well-known randomized controlled trials, to gather information that may lead to individualized patient care.
In 2007, RaySearch Laboratories AB and TomoTherapy Incorporated (now Accuray) entered into a software licensing and development agreement. Under the agreement, RaySearch developed a product named SharePlan, which was launched by TomoTherapy in 2009.
The first ever Proton Partners International site, specialising in proton beam therapy, has acquired a Blue Phantom2 data acquisition system from IBA to commission its IBA Proteus ONE compact proton therapy machine and Elekta Versa HD linear accelerator.
Many infectious diseases are one and done; people get sick once and then they are protected from another bout of the same illness.
Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.
› Verified 8 days ago